Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8784267 | Seminars in Fetal and Neonatal Medicine | 2018 | 15 Pages |
Abstract
Treatment of a haemodynamically significant patent ductus arteriosus (PDA) in the very preterm infant has been an accepted approach for several decades. However, the rationale for closure of PDA has recently been challenged due to reports of success with conservative approaches and the lack of evidence for longer-term benefits from treatment. In this article, we address an approach to assess treatment of those babies most likely to benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jonathan P. Wyllie, Samir Gupta,